Wuyuan Zhou

558 total citations
26 papers, 452 citations indexed

About

Wuyuan Zhou is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wuyuan Zhou has authored 26 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Wuyuan Zhou's work include MicroRNA in disease regulation (11 papers), Extracellular vesicles in disease (3 papers) and RNA modifications and cancer (3 papers). Wuyuan Zhou is often cited by papers focused on MicroRNA in disease regulation (11 papers), Extracellular vesicles in disease (3 papers) and RNA modifications and cancer (3 papers). Wuyuan Zhou collaborates with scholars based in China and Japan. Wuyuan Zhou's co-authors include Kai Cui, Lu Xu, Sheng Li, Haihong Wang, Wenhua Zhao, Hongying Zhao, Pengfei Sun, Bo Zhang, Jinming Yu and Lei Li and has published in prestigious journals such as World Journal of Gastroenterology, American Journal of Physiology-Gastrointestinal and Liver Physiology and Cell Death and Disease.

In The Last Decade

Wuyuan Zhou

26 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wuyuan Zhou China 13 275 175 160 129 40 26 452
Snahlata Singh India 11 246 0.9× 148 0.8× 205 1.3× 103 0.8× 42 1.1× 14 468
Zhuonan Zhuang China 9 213 0.8× 147 0.8× 150 0.9× 97 0.8× 27 0.7× 16 410
Chun‐Hua Wang China 14 223 0.8× 129 0.7× 126 0.8× 72 0.6× 27 0.7× 20 413
Xuanfu Xu China 13 367 1.3× 156 0.9× 161 1.0× 64 0.5× 33 0.8× 19 499
Ka‐Wo Chan China 7 190 0.7× 152 0.9× 127 0.8× 144 1.1× 18 0.5× 8 376
Chengkun Qin China 16 336 1.2× 242 1.4× 174 1.1× 66 0.5× 55 1.4× 35 559
Wenzhou Ding China 8 183 0.7× 182 1.0× 143 0.9× 67 0.5× 33 0.8× 22 403
Ya-Chin Hou Taiwan 8 173 0.6× 104 0.6× 175 1.1× 102 0.8× 97 2.4× 10 393
Haixing Ju China 10 292 1.1× 187 1.1× 166 1.0× 74 0.6× 35 0.9× 26 527

Countries citing papers authored by Wuyuan Zhou

Since Specialization
Citations

This map shows the geographic impact of Wuyuan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wuyuan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wuyuan Zhou more than expected).

Fields of papers citing papers by Wuyuan Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wuyuan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wuyuan Zhou. The network helps show where Wuyuan Zhou may publish in the future.

Co-authorship network of co-authors of Wuyuan Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Wuyuan Zhou. A scholar is included among the top collaborators of Wuyuan Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wuyuan Zhou. Wuyuan Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Deqiang, et al.. (2024). SCARB1‐encoded circ _0029343 induces p73 splicing to promote growth and metastasis of hepatocellular carcinoma via miR‐486‐5p/SRSF3 axis. Journal of Biochemical and Molecular Toxicology. 38(2). e23646–e23646. 2 indexed citations
2.
3.
4.
5.
Xu, Lu, et al.. (2022). Tumor-suppressor p53 specifically binds to miR-29c-3p and reduces ADAM12 expression in hepatocellular carcinoma. Digestive and Liver Disease. 55(3). 412–421. 4 indexed citations
6.
7.
8.
Zhou, Wuyuan, et al.. (2020). The potential mechanisms of piRNA to induce hepatocellular carcinoma in human. Medical Hypotheses. 146. 110400–110400. 7 indexed citations
9.
Xu, Lu, et al.. (2020). Mir-320b Inhibits Pancreatic Cancer Cell Proliferation by Targeting FOXM1. Current Pharmaceutical Biotechnology. 22(8). 1106–1113. 13 indexed citations
10.
Zhao, Hongying, Wuyuan Zhou, Ye Tao, et al.. (2020). <p>Lower Serum Matrix Metalloproteinase‑9 in Metastatic Patients with Esophageal Squamous Cell Carcinoma After Concurrent Radiotherapy Was Significant for Prognosis</p>. OncoTargets and Therapy. Volume 13. 12857–12866. 3 indexed citations
11.
12.
Zhou, Wuyuan, et al.. (2020). hsa_circ_001653 up‐regulates NR6A1 expression and elicits gastric cancer progression by binding to microRNA‐377. Experimental Physiology. 105(12). 2141–2153. 9 indexed citations
13.
14.
Zhong, Jingtao, Xiaoming Yu, Xiaofeng Dong, et al.. (2018). Downregulation of secreted clusterin potentiates the lethality of sorafenib in hepatocellular carcinoma in association with the inhibition of ERK1/2 signals. International Journal of Molecular Medicine. 41(5). 2893–2900. 10 indexed citations
15.
Zhou, Wuyuan, Jun Shi, Zuoxing Niu, et al.. (2013). SmacN7 enhances the sensitivity of pancreatic cancer cells to tumor necrosis factor-related apoptosis-inducing ligand or gemcitabine. Oncology Letters. 5(6). 1760–1764. 6 indexed citations
16.
Chen, Weiwei, Dexian Zhang, Jujie Sun, et al.. (2012). CXCL12/CXCR4 axis plays pivotal roles in the organ-specific metastasis of pancreatic adenocarcinoma: A clinical study. Experimental and Therapeutic Medicine. 4(3). 363–369. 29 indexed citations
17.
Cui, Kai, Wenhua Zhao, Ailiang Wang, et al.. (2010). The CXCR4-CXCL12 Pathway Facilitates the Progression of Pancreatic Cancer Via Induction of Angiogenesis and Lymphangiogenesis. Journal of Surgical Research. 171(1). 143–150. 57 indexed citations
18.
Zhao, Wenhua, et al.. (2009). [Quantitative analysis and significance of CXCL12 and CXCR4 expression with lymphangiogenesis of pancreatic adenocarcinoma].. PubMed. 47(10). 783–6. 3 indexed citations
19.
Zhang, Bo, Wenhua Zhao, Ming Lv, et al.. (2008). Effect of 5-LOX/COX-2 common inhibitor DHDMBF30 on pancreatic cancer cell Capan2. World Journal of Gastroenterology. 14(16). 2494–2494. 8 indexed citations
20.
Zhang, Bo, et al.. (2007). Expression of vascular endothelial growth factors-C and -D correlate with evidence of lymphangiogenesis and angiogenesis in pancreatic adenocarcinoma. Cancer Detection and Prevention. 31(6). 436–442. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Snahlata Singh Breakdown of academic impact, for papers by Zhuonan Zhuang Breakdown of academic impact, for papers by Chun‐Hua Wang Breakdown of academic impact, for papers by Xuanfu Xu Breakdown of academic impact, for papers by Ka‐Wo Chan Breakdown of academic impact, for papers by Chengkun Qin Breakdown of academic impact, for papers by Wenzhou Ding Breakdown of academic impact, for papers by Ya-Chin Hou Breakdown of academic impact, for papers by Haixing Ju
Rankless by CCL
2026